Synthesis and in vitro Anticancer Activity of Ruthenium–Cymene Complexes with Cyclohexyl‐Functionalized Ethylenediamine‐N,N′‐diacetate‐Type Ligands

Abstract

Herein we describe the synthesis, characterization, and anticancer activity of novel p-cymeneruthenium(II) complexes containing methyl, ethyl, n-propyl, and n-butyl esters of (S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, (1)H, and (13)C NMR characterization reveal that ligand coordination occurs through nitrogen donor atoms of the ester ligands, with the organoruthenium moiety being kept in complex. These ruthenium(II) complexes are cytotoxic toward various cancer cell lines including leukemic HL-60, K562, and REH cells (IC(50): 1.0-20.2 μM), with the n-butyl ester complex being the most effective. It causes apoptotic cell death associated with mitochondrial depolarization, caspase activation, phosphatidylserine exposure, and DNA fragmentation. Importantly, the n-butyl ester complex is more effective against leukemic patients' blood mononuclear cells relative to those from healthy control subjects, thus indicating a fairly selective antileukemic action of Ru(II)-based compounds.

Strong in Vitro Cytotoxic Potential of New Ruthenium–Cymene Complexes

“…The conductivity of the solution depends on the electrolyte type, but it depends on the solvent as well. From the observed conductivities and based on the literature data, 34 we concluded that both complexes are a 1:1 type of electrolytes.…”

Ruthenium–arene complexes with NSAIDs: synthesis, characterization and bioactivity

“…11 Because the concentration of oxygen in tumor cells is low, the environment is more reductive than in normal tissue, favouring the active reduced form. 8,12 A real revolution in medicine occurred with the discovery of non-steroidal anti-inflammatory drugs (NSAIDs), which have been proven to be biologically active compounds. NSAIDs are one of the most commonly used classes of medication.…”

Synthesis and biological evaluation of 99mTc tricarbonyl complex of O,O′‐diethylethylenediamine‐N,N′‐di‐3‐propanoate as potential tumour diagnostic agent

“…The n-butyl ester was more efficient in comparison to acid from the same group of ligands. [10,11] These results have motivated our group to investigate the potential of some of the R 2 eddp-type esters for tumour targeting with a simple and convenient radiotracer method. Ga) have an important role in nuclear medicine either as diagnostic or therapeutic radiopharmaceuticals.…”